Vimarsana
Biggest News Aggregation in the World

Page 7 - Concept Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Concept Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Concept Study Today - Breaking & Trending Today

MOL Completes Concept Study of 'Ammonia/Liquefied CO2 Carrier' | Hellenic Shipping News Worldwide - Vimarsana News

MOL Completes Concept Study of 'Ammonia/Liquefied CO2 Carrier' | Hellenic Shipping News Worldwide

Mitsui O.S.K. Lines, Ltd. yesterday announced the completion of a concept study on an ammonia/liquefied CO2 carrier to flexibly meet future demand for transport of liquefied CO2 and ammonia transport with a vessel type that could become the mainstream in this transport field. MOL cooperated with the Mitsubishi Heavy Industry (MHI) Group’s Mitsubishi Shipbuilding Co., ...

Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting - Vimarsana News

Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting

Maximally sustaining IL-6 suppression in a chronic disease like NMOSD and enabling subcutaneous dosing every four weeks. Positive Phase III results for ENSPRYNG, as both monotherapy and in... | March 25, 2022

F. Hoffmann-La Roche Ltd: Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting - Vimarsana News

F. Hoffmann-La Roche Ltd: Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting

First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis and further data in primary progressive MS will be presentedEvrysdi data continue

LATEST FINDINGS ON LECANEMAB - CLINICAL EFFICACY, ARIA RATES, BIOMARKERS RELATIONSHIP TO CLINICAL OUTCOMES AND DOSING REGIMENS - Vimarsana News

LATEST FINDINGS ON LECANEMAB - CLINICAL EFFICACY, ARIA RATES, BIOMARKERS RELATIONSHIP TO CLINICAL OUTCOMES AND DOSING REGIMENS

/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...

Impel NeuroPharma Provides Updates on Trudhesa™ Launch and Recent Business Highlights - Vimarsana News

Impel NeuroPharma Provides Updates on Trudhesa™ Launch and Recent Business Highlights

Impel NeuroPharma Provides Updates on Trudhesa™ Launch and Recent Business Highlights - read this article along with other careers information, tips and advice on BioSpace